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The recently published article by Conzelmann et al., based on the GERAADA
registry, provides further multicentre evidence from a large number of patients
that organ malperfusion represents a key factor for mortality in acute Stanford
type A aortic dissection (AD), with death rates increasing proportional to the
number of affected organs [1, 2]. This concept critically applies also to Stanford
type B AD, where non-surgical options play a primary role. In our strive to
continuously improve outcome, these findings primarily imply that tailored
strategies to revert organ malperfusion should start as early as possible in con-
junction with aortic repair, and should take advantage of an expert multidiscip-
linary ‘aortic team’. A major challenge in front of us, however, is represented by
the unclear definition of organ malperfusion syndromes in AD. This negatively
affects both clinical practice and research, and leads to poor recognition of the
substantial clinical heterogeneity of patients with AD. Unfortunately, in spite of
its leading role in identifying perfusion as a key pathophysiological and prog-
nostic factor, the GERAADA registry itself does not provide any provisional def-
inition of malperfusion syndromes applicable to clinical practice and to further
studies, as the diagnosis of malperfusion was operator-/centre-specific [1–3].
In the current era, a large amount of data exploring organ perfusion three-
dimensionally can bemade available for patients with AD in a timely fashion and
already in the Emergency Department. These data, awaiting systematic record
and exploration, include objective assessment of neurological status (NIH Stroke
Scale, Glasgow Coma Scale, Modified Rankin Scale), ECG findings, bedside
ultrasonography of the heart and vessels, biomarkers exploring organ damage
(myocardium: troponin; kidney: cystatin C, neutrophil gelatinase-associated
lipocalin, creatinine; visceral organs: lactate dehydrogenase, amylase, transami-
nases; muscle: creatine kinase, lactate dehydrogenase), microperfusion (lactate),
systemic inflammation (white blood cells, C-reactive protein), thrombotic burden
(D-dimer, fibrinogen, platelets) and increasingly detailed imaging data. For stand-
ardization, these variables could be classified in predefined bundles of organ
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damage. A relevant model providing readily applicable methods and criteria
could be sepsis, another multiorgan malperfusion killer [4].
In front of us, we should pave our way towards two major objectives. First,
meta-analytic studies combining large registries of AD now have a chance
to provide clinicians, especially emergency physicians from non-specialized
centres, with simple assessment tools based on few unequivocal variables (e.g.
age, gender, haemodynamics, coma, necessity to resuscitate) for the identifica-
tion of the sickest patients. This will favour well-balanced clinical management
and communication with patients’ family members, while limiting heroic thera-
peutic decisions. Second, a new era of multidimensional evaluation and treat-
ment of organ perfusion with measurable criteria and end-points has come,
which will allow us to continuously improve the outcomes of AD.
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We thank Morello et al. for their interest in our work [1–3]. Their demand for
a ‘provisional definition of malperfusion syndromes’ is well comprehensible,
but this was neither the primary intention of the GERAADA (German Registry
for Acute Aortic Dissection Type A) registry, nor possible to achieve by the col-
lected parameters of the registry. The variables for the GERAADA registry were
defined long time before the onset of the registry in July 2006, comprising the
presence or absence of coronary, cerebral, spinal, visceral, renal and peripheral
malperfusions as well as neurological symptoms. Thus, for the purpose of
predicting lethal risk factors, the registry includes a detailed inventory of
malperfused organ systems. A more detailed collection of ‘malperfusion’ para-
meters—as specified by the authors (e.g. biomarkers and imaging data)—may
be worthwhile. But as we had already mentioned in our paper (see Limitations
section), the limited amount of data for the GERAADA registry was deliberately
designed to keep the data recruitment as simple as possible. Concerning data
input into registries, the quality and reliability of too many variables is question-
able and might introduce undesirable bias. Furthermore, to analyse questions,
where multiple parameters or interactions of parameters should reveal a signifi-
cant impact, a cohort of 2137 patients is most likely underpowered. Sometimes
less is more; therefore, we are convinced that our analyses with the limited
amount of data are appropriate for the predefined aim of this study. And it was
one of our intentions to direct the focus on one important issue: the presence
or absence of malperfusion syndromes, which has a tremendous impact on the
patient’s fate.
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